Jennifer Doudna is a scientist who has achieved excellence in the field of gene editing, and her upbringing is full of tenacity and perseverance, demonstrating her love and pursuit of science. It is these qualities that have made her a shining star in today's scientific community.
Doudna was one of the first scientists to begin studying RNA structures. She and her team successfully pinpointed the position of each atom in the self-spliced RNA molecule, as well as the three-dimensional structure. This is a landmark achievement that illustrates how RNA can become an enzyme if it self-cuts, splices, and replicates. This discovery not only earned Dudna a reputation in the academic world, but also opened the door to the field of gene editing for her.
In the field of gene editing, Doudna continues to conduct in-depth research and has achieved a series of remarkable results. She led the team to develop a gene editing technology called CRISPR-Cas9, which is extremely accurate and efficient, providing a powerful tool for hereditary diseases, improving crop quality, and more. Doudna has not only won wide acclaim from the international scientific community, but also numerous honors and awards.
However, Doudna's achievements have not been without its challenges. In her pursuit of science, she has encountered setbacks and difficulties. Looking back on Doudna growing up, it is not difficult to find that her success is inseparable from strong faith, hard work and unremitting pursuit. Her story tells us that as long as we have dreams and move forward bravely, we will be able to create our own brilliance on the road of science.
Women can also become scientists
Doudna was born on February 19, 1964, in Washington, D.C., the eldest daughter of two younger sisters. Doudna spent his childhood in a family with an academic atmosphere. Her father, Martin, was a professor of literature with a keen interest in the field of science. Martin often borrowed books from the local library or bought books at second-hand bookstores for Dudna to read. When Doudna was in sixth grade, she came home from school one day and found a second-hand paperback copy of The Double Helix in her bed, a famous book by James Watson that tells the story of Watson and Clarke's collaboration to discover DNA. This book changed Doudna's life and shaped her future career.
The book also mentions a female scientist, Rosalind Franklin, a structural biologist and crystallographer. She used X-ray diffraction to obtain the first crystal diffraction of DNA**, which is "**51". However, due to the sexist nature of the research environment at the time, her significant discovery was not given the recognition it deserved. Unbeknownst to Franklin, her leader, Wilkins, gave the sheet to two other scientists, James Watson and Francis Crick, who deduced the double helix structure of the DNA based on it. Watson, Crick and Wilkins were awarded the Nobel Prize in Physiology in 1962. Rosalind's story inspired Doudna to truly realise for the first time that women can be great scientists.
In her subsequent studies, she suffered many failures and setbacks, but her father always encouraged her not to give up and to believe in her own abilities and potential. It is this encouragement and support that has enabled Doudna to maintain a strong belief and positive attitude in the face of difficulties.
The path to study and scientific research
In high school, Doudna developed a keen interest in scientific research. After graduating from high school, she chose to intern in the lab of a renowned bacteriologist at the University of Hawaii, which laid a solid foundation for her future research career.
In 1981, Doudna attended Pomona College in Claremont, California, where he studied chemistry and biochemistry. Here, she laid a solid academic foundation.
In 1986, Doudna graduated from Pomona College and successfully applied for graduate school at Harvard University. This world-class university provides her with a wealth of academic resources and a top-notch laboratory environment. Here, she was able to work with many distinguished scientists and delve deeper into the mysteries of science. With her outstanding talent and hard work, she earned her Ph.D. from Harvard University. During his time at Harvard, Doudna became involved in the study of RNA structure and function.
In September 1996, Doudna and colleagues published a report on the discovery of RNA structure in the journal Science. This article won her recognition from the scientific community and established her research position in the field of RNA. After completing his studies at Harvard, Doudna continued his dedication to scientific research, especially in the field of gene editing.
On June 28, 2012, Doudna and Emmanuelle Charpentier preemptively published an important article in the journal Science, spurring a new stage in the field of biotechnology. Together, they developed CRISPR-Cas9 technology and demonstrated for the first time in vitro that a CRISPR system using Cas9 can cleave arbitrary DNA strands. This article marks a breakthrough in the field of gene editing with CRISPR-Cas9 technology and lays the foundation for subsequent widespread applications.
Gene decoder
Doudna has made significant achievements in the field of RNA structure research, winning numerous accolades, including the 1996 Beckham Young Investigator Award, the Alan Waterman Award, and the Eli Lilly & Company Award in biochemistry. In 2002, she was elected a member of the National Academy of Sciences and in 2003 she was elected a member of the American Academy of Arts and Sciences.
However, Doudna's greatest scientific achievement is undoubtedly her research on CRISPR gene editing methods. The CRISPR-Cas9 genome editing method enables precise modification of genes to alter the genotype of target cells. This technology is extremely accurate and efficient, providing a powerful tool for hereditary diseases, improving crop quality, and more.
At present, several companies around the world are developing new CRISPER gene editing**. In December 2023, the U.S. Food and Drug Administration (FDA) announced that it approved the marketing of Casgevy, the first CRISPR Cas9 gene editing, for sickle cell disease (SCD). Two global clinical trials of Casgevy have shown positive results. Twenty-eight of the 29 people with sickle cell disease no longer experience severe pain. Of the 42 people with thalassemia, 39 no longer needed blood transfusions for at least one year.
Competition with Zhang Feng
The rivalry between Doudna and Zhang Feng in the field of gene editing can be said to be a story full of drama and turning points. Both scientists are highly regarded for their contributions to CRISPR-Cas9 technology. But their cooperation and competition have also added a topic worth discussing in this field.
Zhang Feng is a Chinese biologist born in Shijiazhuang, Hebei Province in 1982. At the age of 11, he followed his mother to the United States. Since middle school, he has shown a desire and talent to study computer science and molecular biology. He received his B.S. in Chemistry and Physics from Harvard University and his Ph.D. in Chemical and Biological Engineering from Stanford University. Feng Zhang joined MIT in 2011 and began his own independent research at the Broad Institute.
Zhang Feng is best known for his research in the field of gene editing. In 2013, his lab first applied CRISPR gene editing technology to mammalian and human cells. Since then, he has developed and improved a variety of gene editing tools and is known as one of the pioneers in this field. He has also received several accolades for this breakthrough, including being named one of the Top 10 Scientific Figures of the Year in 2013 by Nature magazine and receiving the Gairdner International Prize in Canada. In addition, Zhang Feng was named one of the 19 most influential scientists in the world in 2015 by Thomson Reuters in 2016.
The rivalry between Doudna and Zhang originated from the battle for patents for the CRISPR-Cas9 technology. They all recognized the potential for great value in this technology and wanted to be recognized for their patents. This led to a fierce competition between the two in an attempt to prove themselves as major contributors to the technology. This kind of competition has promoted the progress of technology to a certain extent, but it has also caused a lot of controversy and doubts.
In the process of competition, both Dudna and Zhang Feng have shown extremely high scientific research strength and perseverance. Interestingly, despite the rivalry between the two, they have also shown a cooperative attitude at some point. For example, in the face of the pandemic, the two sides put aside their differences and worked together to share their scientific findings to develop coronavirus detection tools.
In addition, the rivalry between Doudna and Zhang Feng has sparked discussions about scientific ethics and academic norms. It has been argued that this competition is too fierce and could undermine the atmosphere of unity and cooperation in the scientific community; It is also believed that this kind of competition helps to promote scientific progress and development. In any case, the competition between the two has brought a lot of food for thought and enlightenment to the scientific community.
Gene editing
The value of gene editing is reflected in many aspects, not only providing new tools and methods for scientific research, but also showing broad application prospects in medicine, agriculture, environmental protection and other fields.
First of all, gene editing technology can precisely control and study genes, providing new perspectives and tools for research in the field of genes and life sciences. By editing specific genes, scientists can better understand the function and life process of genes, which in turn can provide new ideas and methods for disease prevention and prevention.
Secondly, the application of gene editing in the medical field is also of great significance. For example, gene editing technology can help repair genetic diseases caused by mutations in a single gene, such as sickle cell disease, thyroxine transporter amyloidosis, transfusion-dependent thalassemia, etc. In addition to genetic diseases, gene editing can also be used in cancer**, targeting specific genes in cancer cells for precision**.
In agriculture, gene editing technology also shows great potential. By editing crops' genes, scientists can improve crop quality, disease resistance and yield, improving agricultural productivity and food quality. At the same time, gene editing can also improve the nutritional value of crops, making them rich in important nutrients, such as vitamins and minerals, thereby improving people's dietary health.
In addition, gene editing also plays an important role in the field of environmental protection. By editing the genes of endangered species, scientists can increase their adaptability, protect endangered species, and restore ecosystems. This contributes to the maintenance of biodiversity and the preservation of the ecological balance of the planet.
It is important to note that gene editing technology also poses a number of ethical and safety concerns. For example, gene editing of human embryos may raise unintended or ethical issues. Therefore, when applying gene editing technology, it is necessary to strictly adhere to relevant safety regulations and standards to ensure its safety and efficacy.
crisprTechnology
CRISPR technology, which stands for clustered regularly interspaced short palindromic repeats, is a repeat sequence within the genome of a prokaryote. This technology is derived from an acquired immune system in bacteria and archaea, which allows bacteria to "remember" the viruses that have invaded it and "shred" the DNA of these viruses through a special protease.
Specifically, when some bacteria are invaded by a virus, they are able to store a small piece of the viral gene in their DNA, and this storage space is called CRISPR. When these bacteria encounter the same virus again, they are able to recognize the virus based on previously stored fragments of viral genes and use CAS proteins (proteins encoded by CRISPR-associated genes) to cut off the virus's DNA, rendering it ineffective.
In recent years, the modified CRISPR Cas9 system has become the most popular gene editing technology in the world, known as the "magic scissors" for editing genes. This technology is simple, inexpensive, and efficient, and has been widely used in biological, pharmaceutical, and agricultural fields. Researchers were able to use this technology as a tool to precisely alter the DNA sequence they wanted to modify, which was far easier than synthesizing an enzyme.
Nobel Prize
In 2020, Doudna and Charpentier were jointly awarded the Nobel Prize in Chemistry for their transformative contributions to the CRISPR-Cas9 gene scissors. This technology is considered the key to "rewriting the code of life" and has brought unprecedented breakthroughs in the field of life sciences. It is worth noting that only 8 years elapsed between the publication of their CRISPR-related discoveries and their winning of the Nobel Prize, which is rare in the history of the Nobel Prize.
Doudna and Charpentier are also the first female scientists to win the Nobel Prize at the same time, a fact that is also rare in the history of the Nobel Prize. Women have traditionally been a minority among the winners of the Natural Sciences Prize, and their awards have undoubtedly set an example for female scientists and broken the stereotype of gender in science.
After receiving the award, Doudna did not stop at the honor, but continued to devote himself to scientific research. In the year since winning the award, she has reportedly led a team to develop a novel CRISPR-CSM system that has a 10-fold lower off-target rate than previous CRISPR technology. This breakthrough may accelerate the safe application of gene editing, providing more precise and safe tools for future medical research and **.
Public Scientists
In the process of achieving a series of major scientific achievements, Doudna gradually began to think deeply about the relationship between scientific progress and social responsibility.
First, Doudna emphasized openness and transparency in scientific research. She believes that the sharing and disclosure of scientific knowledge is an important foundation for promoting scientific progress. By publishing research results, scientists can learn from each other, collaborate, and jointly advance the development of the scientific field. At the same time, openness also helps the public understand the progress and potential risks of scientific research, so that they can make more informed decisions.
Second, Doudna is concerned with the ethical and social implications of scientific research. She believes that scientists should take full account of their social and ethical implications when conducting research, and take responsibility for it. Especially in areas where human health and life safety are involved, scientists need to be cautious. Doudna is also an active advocate for ethical review and regulation of cutting-edge technologies such as gene editing to ensure the proper application of these technologies.
In addition, Doudna called for greater public understanding and participation in science. She believes that public understanding and support for science is an important driving force for the development of science. Therefore, she actively participates in popular science activities, popularizing scientific knowledge to the public, and explaining the principles and applications of scientific research. At the same time, she advocates for policymakers to pay attention to developments in the field of science and formulate sound policies to support scientific research and innovation.
Doudna is not only due to her personal contributions and honors, but also to the scientific spirit and innovative power she represents. Her story tells us that with strong faith and unremitting efforts, the power of science can bring more hope and possibilities to mankind.
ENDS).